Metformin use is associated with better survival of diabetic patients with pancreatic cancer.

Abstract

PURPOSE Accumulating evidence suggests that metformin has antitumor activity. The aim of this study was to determine whether metformin use has a survival benefit in patients with pancreatic cancer. EXPERIMENTAL DESIGN We conducted a retrospective study of patients with diabetes and pancreatic cancer treated at The University of Texas MD Anderson Cancer… (More)
DOI: 10.1158/1078-0432.CCR-11-2994

5 Figures and Tables

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics